| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.4 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.4 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.4 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |